Verdijk P, et al. First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
Sierra MS, et al. Risk factors for non-human papillomavirus (HPV) Type 16/18 cervicalInfections and associated lesions among HPV DNA-negative women vaccinated against HPV-16/18 in the Costa Rica vaccine trial.
Bonde J, et al. Methylationmarkers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirusscreen positive women: A large European multicenter study.
Koraka P, et al. Analysis of mouse brain transcriptome after experimental Duvenhage virus infection shows activation of innate immune response and pyroptotic cell death pathway.